Germline-encoded recognition of peanut underlies development of convergent antibodies in humans., PMID:40498852
Characterization of IgE cross-reactivity and allergenicity of peanut allergens., PMID:40447301
Evaluation of peanut tolerance in sensitized mice through intradermal allergen delivery with adjuvants., PMID:40328343
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding., PMID:40311815
A dual-functional paper-based analytical device for ultrasensitive detection of peanut allergen-specific IgE., PMID:40210278
Exploring geographical variances in component-resolved diagnosis within the Asia-Pacific region., PMID:40105317
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy., PMID:39887792
Antigenic determinants underlying IgE-mediated anaphylaxis to peanut., PMID:39814145
Structural determinants of peanut-induced anaphylaxis., PMID:39805366
Ara h 2-expressing cucumber mosaic virus-like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals., PMID:39756833
Diagnostic Accuracy of Lipid Transfer Proteins (LTPs) Specific IgE Assay in Food Allergy: A Systematic Review., PMID:39684636
Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial., PMID:39505279
Preclinical efficacy of peanut-specific IgG4 antibody therapeutic IGNX001., PMID:39069172
Longitudinal peanut and Ara h 2 specific-IgE, -IgG4, and -IgG4/-IgE ratios are associated with the natural resolution of peanut allergy in childhood., PMID:38720169
Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy., PMID:38460677
NOVEOS and ImmunoCAP Have Similar Performances for Diagnosing Food Allergies., PMID:38458433
Novel post-translationally cleaved Ara h 2 proteoforms: Purification, characterization and IgE-binding properties., PMID:38447836
A novel IgE epitope-specific antibodies-based sandwich ELISA for sensitive measurement of immunoreactivity changes of peanut allergen Ara h 2 in processed foods., PMID:38439921
Optimising the management of peanut allergy by targeting immune plasticity., PMID:38423799
The structure and potential allergenicity of peanut allergen monomers after roasting., PMID:38353700
CD23+IgG1+ memory B cells are poised to switch to pathogenic IgE production in food allergy., PMID:38324641
Serologic measurements for peanut allergy: Predicting clinical severity is complex., PMID:38272114
The Sensitization Profile for Selected Food Allergens in Polish Children Assessed with the Use of a Precision Allergy Molecular Diagnostic Technique., PMID:38255900
Design of an Ara h 2 hypoallergen from conformational epitopes., PMID:38168500
AIT 2023: Current innovation and future outlook., PMID:38143940
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy., PMID:38009299
Investigation of peanut allergen-procyanidin non-covalent interactions: Impact on protein structure and in vitro allergenicity., PMID:38000575
Corrigendum: Biological activity of human IgE monoclonal antibodies targeting Der p 2, Fel d 1, Ara h 2 in basophil mediator release assays., PMID:37885892
EAACI guidelines on the diagnosis of IgE-mediated food allergy., PMID:37815205
Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy., PMID:37748654
Clinical severity of LTP syndrome is associated with an expanded IgE repertoire, FDEIA, FDHIH, and LTP mono reactivity., PMID:37712443
Alanine Scanning of the Unstructured Region of Ara h 2 and of a Related Mimotope Reveals Critical Amino Acids for IgE Binding., PMID:37706599
Immunocomplexed Antigen Capture and Identification by Native Top-Down Mass Spectrometry., PMID:37683262
The combination of Ara h 2-sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy., PMID:37622254
Ara h 2 Peptide Mix Improves the Diagnosis of Peanut Allergy and Is Relevant for Ara h 2-Induced Mast Cell Activation., PMID:37495080
Risk Factors for Anaphylaxis in Children Allergic to Peanuts., PMID:37374241
IgE Recognition and Structural Analysis of Disulfide Bond Rearrangement and Chemical Modifications in Allergen Aggregations in Roasted Peanuts., PMID:37256970
Biological activity of human IgE monoclonal antibodies targeting Der p 2, Fel d 1, Ara h 2 in basophil mediator release assays., PMID:37228609
Developing a Prediction Model for Determination of Peanut Allergy Status in the Learning Early About Peanut Allergy (LEAP) Studies., PMID:37146884
Soy Gly m 8 sIgE Has Limited Value in the Diagnosis of Soy Allergy in Peanut Ara h 2-Sensitized Adults., PMID:37071975
Ara h 2-specific IgE epitope-like peptides inhibit the binding of IgE to Ara h 2 and suppress lgE-dependent effector cell activation., PMID:37038893
IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex formation of both major peanut allergens., PMID:37028524
Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children., PMID:36916639
Cross-Serological Reaction of Glandless Cottonseed Proteins to Peanut and Tree Nut Allergic IgE., PMID:36838575
A molecular sensitization map of European children reveals exposome- and climate-dependent sensitization profiles., PMID:36815272
Peanut allergen inhibition prevents anaphylaxis in a humanized mouse model., PMID:36753563
The memory of pathogenic IgE is contained within CD23 + IgG1 + memory B cells poised to switch to IgE in food allergy., PMID:36747707
Structure and IgE Cross-Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin-Buried Peptides., PMID:36728846
Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice., PMID:36704937
Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy., PMID:36647835
For research use only. Not for human or drug use.
